Wilson, Frederick H <br/><br/>
A functional landscape of resistance to ALK inhibition in lung cancer.  [electronic resource] 

 -  Cancer cell  Mar 2015 
 - 397-408 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-3686 
<br/><br/><label>Standard No.: </label>10.1016/j.ccell.2015.02.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anaplastic Lymphoma Kinase<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Line, Tumor<br/>Crizotinib<br/>Drug Resistance, Neoplasm--genetics<br/>ErbB Receptors--genetics<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Pyrazoles--pharmacology<br/>Pyridines--pharmacology<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Receptor, ErbB-2--genetics<br/>Receptors, Purinergic P2Y--genetics<br/>Signal Transduction--drug effects